GSK-J4 suppresses the KDM6B-mediated proinflammatory response in macrophages [121], reduces tumor volume in mice xenografts of an ovarian cancer model [122], and reduces T-ALL xenograft growth in a mouse model [123]. This evidence concerns the gene KDM6B and neoplasm.